Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF DECEMBER 24, 2021 SAM #7328
SPECIAL NOTICE

65 -- V-PLEX SARS-CoV-2 Panel 13 and 14 (IgG) Kits

Notice Date
12/22/2021 12:15:34 PM
 
Notice Type
Special Notice
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
NOI-NIAID-2105227
 
Response Due
12/27/2021 9:00:00 AM
 
Point of Contact
Maliaka Pinkney, Phone: 2406695308, Julienne Keiser, Phone: 4063639370
 
E-Mail Address
maliaka.pinkney@nih.gov, jkeiser@niaid.nih.gov
(maliaka.pinkney@nih.gov, jkeiser@niaid.nih.gov)
 
Description
This is a Notice of Intent, not a request for proposal.� The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Meso Scale Discovery will provide the V-PLEX SARS-CoV-2 Panel 13 and 14 (IgG) Kits. The National Institute of Allergy and Infectious Diseases (NIAID) has an urgent requirement for the V-PLEX SARS-CoV-2 Panel 13 and 14 kits for use in the COVID-19 research. As the threat of COVID-19 continues in the international community with new variants emerging every week, the need for a safe and efficacious monoclonal antibody therapy at an accelerated timeline is a health care priority. To assist in this effort, the VRC-VIP will use the electrochemiluminescent (ECL) assay format which they have recently developed for a SARS CoV-2 specific assay for the detection of specific antibodies directed towards SARS CoV-2 S-2P (or other stabilized version of this same protein), SARS CoV-2 Receptor Binding Domain (RBD) and SARS CoV-2 N ( nucleocapsid proteins), SARS-CoV-2 NTD, SARS CoV-2 S1, SARS CoV-2 S2, and variant spikes (P.1, B.1.1.7, B.1.351, B.1.526.1, A.23.1, A.VOI.V2, B.1.617.2, C.37, R.1, P.3, B.1.525, B.1.1.519, BV-1). The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.� All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2105227 to Maliaka Pinkney at maliaka.pinkney@nih.gov, by 12:00 pm eastern standard time Tuesday, December 27, 2021.� All responses received by the closing date of this synopsis will be considered by the Government.� A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/fb34d266aec54864a3857aeb5594a13f/view)
 
Place of Performance
Address: Gaithersburg, MD 20878, USA
Zip Code: 20878
Country: USA
 
Record
SN06203491-F 20211224/211222230109 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.